The table below shows Day One Biopharmaceuticals, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Revenue
$39.80M
$33.91M
$30.76M
$93.76M
$8.19M
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$31.42M
$36.15M
$39.62M
$33.56M
$92.11M
$40.21M
SG&A
DAWN annual revenue (10-K history)
Day One Biopharmaceuticals, Inc. reported annual revenue of $158.18M for fiscal year 2025. That is up 20.6% from $131.16M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.